Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.5009
BATS BZX Real-Time Price
As of 1:02pm ET
 -0.0071 / -1.40%
Today’s Change
0.28
Today|||52-Week Range
1.08
+62.42%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.51
Today’s open0.49
Day’s range0.49 - 0.50
Volume27,328
Average volume (3 months)2,341,278
Market cap$130.6M
Dividend yield--
Data as of 1:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+66.86%
P/E ratioNM
Price/Sales1.71
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd-0.05-0.83%
--EcoGreen Internation...-0.00-0.52%
AGTCApplied Genetic Tech...-0.25-3.38%
DRRXDURECT Corp0.000.00%
Data as of 12:46pm ET, 02/24/2017

Financials

Next reporting dateMarch 10, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$44.7M
Annual profit (last year)-$55.7M
Net profit margin-124.54%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts


Search for Jobs